Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 2, 2005, Pages 921-930

  Kantor, Sandor ^a   Jakus, Rita ^a   Molnar, Eszter ^a   Gyongyosi, Norbert ^a   Toth, Attila ^d   Detari, Laszlo ^d   Bagdy, Gyorgy ^a,b,c  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CHLORDIAZEPOXIDE; CYTIDINE DIPHOSPHATE; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAM; MALE; MULTICHANNEL RECORDER; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; SLOW BRAIN WAVE; SLOW WAVE SLEEP; SOCIAL INTERACTION; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TRANQUILIZING ACTIVITY; WAKEFULNESS;

ACOUSTIC STIMULATION; AMINOPYRIDINES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AROUSAL; CEREBRAL CORTEX; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; INDOLES; MALE; POLYSOMNOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS; SLEEP; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; THETA RHYTHM;

EID: 27144503119     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.086413     Document Type: Article

References (53)

1. Abramowski D, Rigo M, Duc D, Hoyer D, and Staufenbiel M (1995) Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34:1635-1645.
2. Achermann P and Borbely AA (2003) Mathematical models of sleep regulation. Front Biosci 8:s683-s693.
3. Acsady L, Arabadzisz D, Katona I, and Freund TF (1996) Topographic distribution of dorsal and median raphe neurons with hippocampal, septal and dual projection. Acta Biol Hung 47:9-19.
4. Argyropoulos SV and Nutt DJ (1999) The use of benzodiazepines in anxiety and other disorders. Eur Neuropsychopharmacol 9 (Suppl 6):S407-S412.
5. Bagdy G, Graf M, Anheuer ZE, Modos EA, and Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399-408.
6. 2C receptor antagonist. Neuropharmacology 36:621-629.
7. Borbely AA (1995) Principal sleep regulation: implications for the effect of hypnotics on sleep, in Handbook of Experimental Pharmacology: Pharmacology of Sleep (Kales A ed) pp 29-45, Springer-Verlag, Berlin, Germany.
8. Borbely AA and Achermann P (1991) Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol 195:11-18.
9. Borbely AA, Trachsel L, and Tobler I (1988) Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol 156:275-278.
10. Bromidge SM, Dabbs S, Davies S, Duckworth DM, Forbes IT, Jones GE, Jones J, King FD, Saunders DV, Blackburn TP, et al. (2000) 1-[2-[(Heteroaryloxy) heteroaryl] carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents. Bioorg Med Chem Lett 10:1863-1866.
11. Buffett-Jerrott SE and Stewart SH (2002) Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 8:45-58.
12. Buzsaki G (2002) Theta oscillations in the hippocampus. Neuron 33:325-340.
13. Clemett DA, Punhani T, Duxon MS, Blackburn TP, and Fone KC (2000) Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39:123-132.
14. Danjou P, Warot D, Hergueta T, Lacomblez L, Bouhours P, and Puech AJ (1992) Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses. Int Clin Psychopharmacol 7:73-79.
15. Dekeyne A, Denorme B, Monneyron S, and Millan MJ (2000) Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology 39:1114-1117.
16. Detari L, Szentgyorgyi V, Hajnik T, Szenasi G, Gacsalyi I, and Kukorelli T (1999) Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats. Psychopharmacology 142:318-326.
17. 2 antagonist and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207-218.
18. Di Matteo V, De Blasi A, Di Giulio C, and Esposito E (2001) Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 22:229-232.
19. Eberle-Wang K, Mikeladze Z, Uryu K, and Chesselet MF (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384:233-247.
20. Eccles CU (1988) EEG correlates of neurotoxicity. Neurotoxicol Teratol 10:423-428.
21. File SE and Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53.
22. Frank MG, Stryker MP, and Tecott LH (2002) Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor. Neuropsychopharmacology 27:869-873.
23. Gerbrandt LK, Lawrence JC, Eckardt MJ, and Lloyd RL (1978) Origin of the neocortically monitored theta rhythm in the curarized rat. Electroencephalogr Clin Neurophysiol 45:454-467.
24. Givens B and Olton DS (1995) Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area. Neurobiol Learn Mem 63:269-276.
25. Guy AP and Gardner CR (1985) Pharmacological characterisation of a modified social interaction model of anxiety in the rat. Neuropsychobiology 13:194-200.
26. Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, and Richards JG (1992) Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep and anxiety disorders. Adv Biochem Psychopharmacol 47:379-394.
27. Hajos M, Hoffmann WE, and Weaver RJ (2003) Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 306:605-615.
28. Hasselmo ME, Hay J, Ilyn M, and Gorchetchnikov A (2002) Neuromodulation, theta rhythm and rat spatial navigation. Neural Netw 15:689-707.
29. Holsheimer J and Feenstra BW (1977) Volume conduction and EEG measurements within the brain: a quantitative approach to the influence of electrical spread on the linear relationship of activity measured at different locations. Electroencephalogr Clin Neurophysiol 43:52-58.
30. Kantor S, Jakus R, Balogh B, Benko A, and Bagdy G (2004) Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. Br J Pharmacol 142:1332-1342.
31. 2 receptor antagonist ritanserin on EEG power spectra, motor activity and sleep: changes at the light-dark phase shift. Brain Res 943:105-111.
32. Kennett GA, Whitton P, Shah K, and Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164:445-454.
33. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, et al. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609-620.
34. Klimesch W (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 29:169-195.
35. Koolhaas JM, De Boer SF, De Rutter AJ, Meerlo P, and Sgoifo A (1997) Social stress in rats and mice. Acta Physiol Scand Suppl 640:69-72.
36. Krijzer FN and van der Molen R (1987) Classification of psychotropic drugs by rat EEG analysis: the anxiolytic profile in comparison to the antidepressant and neuroleptic profile. Neuropsychobiology 18:51-56.
37. Kunsman GW, Manno JE, Manno BR, Kunsman CM, and Przekop MA (1992) The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam. Br J Clin Pharmacol 34:289-301.
38. Leranth C and Vertes RP (1999) Median raphe serotonergic innervation of medial septum/diagonal band of broca (MSDB) parvalbumin-containing neurons: possible involvement of the MSDB in the desynchronization of the hippocampal EEG. J Comp Neurol 410:586-598.
39. Lucki I, Rickels K, and Geller AM (1986) Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) 88:426-433.
40. Martin JR, Ballard TM, and Higgins GA (2002) Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety. Pharmacol Biochem Behav 71:615-625.
41. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83-244.
42. 2C receptors. Brain Res Mol Brain Res 23:163-178.
43. Portas CM, Bjorvatn B, and Ursin R (2000) Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 60:13-35.
44. Robinson TE (1980) Hippocampal rhythmic slow activity (RSA; theta): a critical analysis of selected studies and discussion of possible species-differences. Brain Res 203:69-101.
45. Roth T (2001) The relationship between psychiatric diseases and insomnia. Int J Clin Pract Suppl. 3-8.
46. 2A-receptors. Br J Pharmacol 135:65-78.
47. Smith MI, Piper DC, Duxon MS, and Upton N (2002) Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine. Pharmacol Biochem Behav 71:599-605.
48. Staubli U and Xu FB (1995) Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory and LTP induction in the freely moving rat. J Neurosci 15:2445-2452.
49. Talk A, Kang E, and Gabriel M (2004) Independent generation of theta rhythm in the hippocampus and posterior cingulate cortex. Brain Res 1015:15-24.
50. Tobler I, Kopp C, Deboer T, and Rudolph U (2001) Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci USA 98:6464-6469.
51. van Laar M, Volkerts E, and Verbaten M (2001) Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers. Psychopharmacology 154:189-197.
52. Vertes RP and Kocsis B (1997) Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 81:893-926.
53. Wu M, Shanabrough M, Leranth C, and Alreja M (2000) Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: implications for learning and memory. J Neurosci 20:3900-3908.